Classifications

• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01D—SEPARATION
  • B01D39/00—Filtering material for liquid or gaseous fluids
  • B01D39/08—Filter cloth, i.e. woven, knitted or interlaced material
  • B01D39/083—Filter cloth, i.e. woven, knitted or interlaced material of organic material
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
  • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
  • A61M1/3621—Extra-corporeal blood circuits
  • A61M1/3627—Degassing devices; Buffer reservoirs; Drip chambers; Blood filters
  • A61M1/3633—Blood component filters, e.g. leukocyte filters
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01D—SEPARATION
  • B01D39/00—Filtering material for liquid or gaseous fluids
  • B01D39/08—Filter cloth, i.e. woven, knitted or interlaced material
  • B01D39/086—Filter cloth, i.e. woven, knitted or interlaced material of inorganic material
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M2202/00—Special media to be introduced, removed or treated
  • A61M2202/04—Liquids
  • A61M2202/0413—Blood
  • A61M2202/0429—Red blood cells; Erythrocytes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M2202/00—Special media to be introduced, removed or treated
  • A61M2202/04—Liquids
  • A61M2202/0413—Blood
  • A61M2202/0439—White blood cells; Leucocytes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M2205/00—General characteristics of the apparatus
  • A61M2205/75—General characteristics of the apparatus with filters
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01D—SEPARATION
  • B01D2239/00—Aspects relating to filtering material for liquid or gaseous fluids
  • B01D2239/12—Special parameters characterising the filtering material
  • B01D2239/1233—Fibre diameter

Definitions

• the present invention relates to an instrument for separating blood components. More specifically, the present invention can efficiently remove both white blood cells mixed in a blood cell suspension such as a red blood cell concentrate and the like with a simple operation in terms of both volume and time, and furthermore, the outflow of filter fiber pieces. Therefore, the blood component separation device which is less likely to be used is used.
• erythrocyte concentrate separated in this way is widely used as a component preparation of erythrocytes for component transfusion to patients who require erythrocytes, but in fact, erythrocyte concentrates contain many leukocytes.
• the concept of a so-called whole blood component, including platelets, is becoming established, and a large amount of white blood cells and platelets are transfused together with the transfusion of red blood cell concentrate to patients who need only red blood cells. Is a problem.
• a hemagglutinating agent such as dextran or hydroxyethyl starch is added to a leukocyte-containing suspension such as CRC, and the coagulant-introducing solution is sedimented, and the solution is separated into an erythrocyte sediment and a leukocyte-containing solution phase.
• a method of flowing a leukocyte suspension through a column filled with fibers and adsorbing and removing leukocytes and platelets is used. It is mainly performed.
• the leukocyte / platelet removal rate can be increased by increasing the packing density of the fibers, but on the other hand, the elongation time becomes longer, and the blood cell removal rate and the blood cell suspension treatment time are improved. It was difficult to make them compatible.
• a method of using ultra-fine fibers themselves or nonwoven fabrics has been proposed (Japanese Patent Publication No. 58-54, 12S, Japanese Patent Application Laid-Open No. 60-193, 468).
• Japanese Patent Application Laid-Open No. 60-193, 468 Japanese Patent Application Laid-Open No. 60-193, 468.
• the microfibers are filled, the above-mentioned problem of the balance between the blood cell removal rate and the processing time cannot be completely solved, and channeling may occur due to the way of weaving the fibers, and there is a risk of fiber pieces flowing out.
• the fibers are firmly fixed together and fixed with an adhesive, etc., the entanglement is insufficient and the fiber fragments can flow out. It was something with the potential.
• an object of the present invention is to provide an improved instrument for separating blood components.
• the present invention also relates to mixing in a blood cell suspension such as a red blood cell concentrate. It is an object of the present invention to provide a blood component separating device which can efficiently remove both white blood cells and platelets by simple operations in both volume and time with a simple operation, and has a low risk of spilling out of a single fiber piece of a filter. I do.
• a housing having a blood cell suspension inlet and a blood cell suspension outlet and applying a plurality of fibers having properties that do not substantially alter the blood cell suspension. It is achieved by a blood component separating device characterized by comprising a filter material filled in at least one kind of housing selected from the group consisting of a yarn woven fabric and a knitted fabric.
• the present invention also provides the filter material shows a 0 ⁇ 2 ⁇ 1.
• O g Z cm 3 blood component separation instrument characterized in that it is filled with bulk density of '.
• the present invention also provides a blood component separating device in which the size of the fabric or the stripes is such that the red blood cells can pass therethrough.
• the present invention further shows a blood component separating device in which the woven fabric or the stripe has a diameter of about 10 to 200 m.
• the present invention also shows an instrument for separating blood components, wherein the textile is a synthetic fiber, a semi-synthetic fiber, a regenerated artificial textile, an inorganic fiber or a natural fiber.
• the present invention provides a method for separating blood components, wherein the fiber is selected from the group consisting of a polyamide, a polyester, a polyacrylonitrile, a polystyrene, a polyolefin, a polyurethane, and an acetate. It shows an instrument. Book
• the invention still further provides a blood component separating device in which the woven or knitted fabric is constituted by fibers having a diameter of about 10 to 50 U.
• the present invention also provides an instrument for separating blood components, wherein the woven or knitted fabric is made of yarn having a diameter of about 10 to 3 ⁇ .
• the present invention further provides a blood component separation device in which the woven or knitted mesh has a diameter of about 100 to 100 m.
• FIG. 1 is a cross-sectional view showing an embodiment of the blood component separation device of the present invention
• FIG. 2 is a drawing showing a processing circuit incorporating the blood component separating device of the present invention.
• the instrument for separating blood components according to the present invention is characterized in that a woven or knitted yarn obtained by loosening a fiber which does not substantially denature a blood cell suspension is used as a filter material.
• a woven or knitted yarn obtained by loosening a fiber which does not substantially denature a blood cell suspension is used as a filter material.
• the "eyes” become flow channels when used as a filter material.
• the "eyes” are arranged in an orderly manner, so that even if the fabrics or animals are stacked and pressed (that is, the packing density is increased), the eyes are secured and red blood cells are obtained. It shows a useful effect as an instrument for separating blood components by rapidly flowing a blood cell suspension such as a concentrated liquid.
• the packing efficiency is better, the packing can be performed at a higher packing density, and the efficiency of removing unnecessary blood cell components can be increased even in the same volume.
• Possible mechanisms for the capture of leukocytes and platelets by fibers include adhesion of leukocytes and platelets to the fibre, and trapping of leukocytes and platelets in the gaps between fibers.
• the use of ultrafine fibers reduces the distance between the fibers and increases the surface area to increase the trapping efficiency.
• a possible method to increase the trapping efficiency by reducing the distance between the fibers and increasing the surface area is to increase the packing density by compressing the filter material. .
• the overspeed will be extremely slow, making it unsatisfactory as a blood component separation device.
• the device for separating blood components of the present invention is provided in at least one type of housing selected from the group consisting of woven and knitted yarns obtained by applying fibers that do not substantially modify blood cell suspension components. Having filled filter material It is characterized by the following.
• Synthetic fibers such as synthetic fibers, semi-synthetic fibers such as acetate, regenerated artificial fibers such as copper ammonia cellulose, inorganic fibers such as glass fibers, and natural fibers such as cotton, silk, and wool.
• the cell suspension can sufficiently pass red blood cells. It is preferably about 0 to 200, more preferably about 10 to 1 °. In this case, the phrase “allow red blood cells to pass” includes the case where red blood cells can deform and pass through.
• the thickness of the yarns of the fibers constituting the woven or knitted fabric is not particularly limited as long as the size of the mesh as described above can be secured. In order to increase the degree, usually the diameter is 200 to 150? ? 1, more preferably about 200 to 100000.
• the fiber yarn is a yarn composed of a plurality of filaments, and the monofilament is 10 to 50 m, more preferably 1 to 30 m.
• FIG. 1 shows an embodiment of the blood component separating device of the present invention.
• the blood component separation device 1 is fitted in a liquid-tight manner at the outer peripheral fitting portions 3 and 3a such that the round tray-shaped housing members 2 and 2a form a space therein,
• the inner space is provided with a filter material formed by laminating a plurality of woven fabrics and Z or knits, sandwiched between the mesh-like support members 4 and 4a.
• a blood cell suspension liquid inlet 6 is provided at the center of one housing member 2 and a blood cell suspension liquid outlet 7 is provided at the center of the other housing member 2a so as to communicate with the internal space. .
• the supports 4, 4a are made of a material such as polyester if they are clear, and support the filter material 5 composed of a plurality of woven fabrics and knots or knits, and at the same time, are formed into a mesh and introduced. It also functions as a flow path regulating unit that makes the fluid flow uniformly.
• the filter material 5 made of woven fabric and z or knitted fabric has a bulk density of 0.2 to 1.0 OgZon 2 , although it is affected by the type and thickness of the fiber. It is stacked and filled to the degree.
• the bulk density of the filter material 5 depends on the permeation speed of the permeated blood cell suspension, the leukocyte trapping ability, etc. Has a large effect on
• the filling amount of the filter material 5 should be 3 to 15 g per 100 ml of a suitable blood cell suspension.
• the blood component separation device 1 having such a configuration is used, for example, as shown in FIG.
• the blood cell suspension liquid bag 8 containing the blood cell suspension to be filtered and the physiological saline bag 9 containing the physiological saline are positioned above the blood component separation device 1 *, and the respective adjustment valves 1 ⁇ a, 10b, and the three-way connector 11a, were connected to the blood cell suspension inflow port of the blood component separation device 1 via the connecting tube 12a, while being positioned below the blood component separation device 1.
• Adjust the collection bag 13 and 14 in the same way. Connect the tube 1 2 to the blood cell suspension outlet 7 of the blood component separation device 1 via the valves 10 c 'and 10 d and the three-way connector lib. b to form a processing circuit.
• the treatment of the blood cell suspension is performed by first priming the inside of the circuit by flowing a physiological saline from the physiological saline bag 9 and then connecting the connecting tube 12a to the blood cell suspension by the natural head method from the blood cell suspension bag 8. Introduced into the blood component chick tool 1 in the same manner.
• the leukocyte suspension introduced into the blood component separation device 1 is captured by white blood cells, platelets, etc. by a filter material made of woven or knitted cloth, and the main component is red blood cells and plasma. Through the collection bag 13.
• the blood cell suspension for the leukocyte and platelet removal operation using the blood component separation device of the present invention includes blood, other body fluids such as ascites and bone marrow fluid, and centrifugal separation of red blood cell concentrate and the like. It includes a blood cell suspension obtained by the operation, a blood cell suspension obtained by adding a hemagglutinating agent such as a hemagglutinating agent, and a blood cell suspension obtained by cell electrophoresis.
• a knitted fabric made of 20 te X yarn from a polyester filament with a diameter of 12 m were placed in a housing space (inner diameter 56 M, filter layer length 21).
• the blood cells were stacked and filled to a bulk density of 0. S gcm 3 to prepare a blood component separation device.
• the above was placed at a drop of 7500 from the blood cell suspension bag 8 containing 200 ml of CPD-added blood.
• a collection bag 13 transfer bag T-200, manufactured by Terumo Corporation
• the leukocyte removal rate and erythrocyte recovery rate were calculated using the automatic blood counting device (ELT-8, manufactured by Orsault) using the number of red blood cells and white blood cells in the blood before and after passing through the filter.
• the absolute amount of each blood cell component was calculated based on the above equation.
• Example 2 The leukocyte removal rate and erythrocyte recovery rate was calculated using the automatic blood counting device (ELT-8, manufactured by Orsault) using the number of red blood cells and white blood cells in the blood before and after passing through the filter.
• the absolute amount of each blood cell component was calculated based on the above equation. Example 2.
• Example 2 The same circuit as in Example 1 was prepared by laminating 9 ⁇ fabrics made of 20 te X yarns from polyester filaments having a diameter of 12 m and laminating them to a bulk density of 0.69 gZ cm 3 . ⁇ Treated blood in a manner. As a result, the blood processing time was 3 minutes, the processing speed per unit area was 2.7 mlZcm 2 Z minutes, the leukocyte removal rate was 99.0, and the red blood cell recovery was 96.0%. .
• a polyester filament with a diameter of 12 m itself is placed in the same housing space as in Example 1 with a bulk density of 0.35 / cm3 (it is difficult to fill with a bulk density higher than that of humans). I got it. >, A device for separating blood components having the same form as in Examples 1 and 2 was prepared. Thereafter, blood was processed by the same circuit and method as in Example 1. At this time, the blood processing time was 4 minutes and 30 seconds, the processing speed per unit area was 2.0 OmlZo! Z minutes, the leukocyte removal rate was 62%, and the red blood cell recovery rate was 93%. .
• Example 2 0.35 gZcm 3 of natural cotton filament itself having an average diameter of 16 u similar to that of Example 3 (it was difficult to fill with a human force at a higher bulk density.)
• the blood was uniformly filled, and the blood was processed by the same circuit and method as in Example 1. At this time, the blood processing time was 7 minutes and 30 seconds, and the processing speed per unit area was 1.1 l.
• the leukocyte removal rate was 94.8%, and the red blood cell recovery rate was 93.2%.
• the present invention provides a blood cell suspension inlet and blood cells.
• a housing having a suspension outlet, and at least one selected from the group consisting of woven and knitted yarns obtained by loosening a plurality of fibers having properties that do not substantially alter the blood cell suspension. Since it is a device for separating blood components, which is composed of a material filled in a housing of a kind, the flow path of the blood cell suspension that is processed even if the packing density of the material of the filter is increased. It is secured, easy to operate, can be removed efficiently and with high trapping capacity in both volume and time, and the yarn of textile is made into fabric and z or animal. There is no risk of fiber spills during cropping, and there is little blood channeling.
• the blood component separating device is characterized in that the filter material is filled with a bulk density of 0.1 to 2.1 g ZC Ill3, and the size of the woven fabric and the Z or knitted fabric is erythrocyte. If the diameter is 10 to 100 to 7 l, the flow rate of the blood component through the woven or knitted fabric is sufficient, and the chance of the blood component coming into contact with the fiber is increased. Better, resulting in better leukocyte and platelet capture, and whether the fibers are of the group consisting of polyamides, polyesters, -polyacrylonitriles, polystyrenes, polyolefins, polyurethanes, and acetates.
• the capture efficiency of leukocytes and platelets on the fiber by adhesion to the fiber is also good, and the capture efficiency is further improved.
• textiles or forceps If it is composed of a yarn having a diameter of about 10 to 30, a better instrument for separating blood components can be obtained from the viewpoint of manufacturability and increasing the packing density.

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Engineering & Computer Science (AREA)
• Textile Engineering (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Heart & Thoracic Surgery (AREA)
• Vascular Medicine (AREA)
• Anesthesiology (AREA)
• Cardiology (AREA)
• Biomedical Technology (AREA)
• Hematology (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Inorganic Chemistry (AREA)
• External Artificial Organs (AREA)
• Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Priority Applications (3)

Applications Claiming Priority (2)

Publications (1)

Family

ID=17017810

Family Applications (1)

Country Status (8)

Cited By (6)

Families Citing this family (6)

Citations (2)

Family Cites Families (8)

• 1987
  • 1987-10-06 CA CA000548716A patent/CA1305052C/en not_active Expired - Fee Related
  • 1987-10-06 AU AU80738/87A patent/AU609741B2/en not_active Ceased
  • 1987-10-06 JP JP62505965A patent/JPH0817813B1/ja not_active Expired - Lifetime
  • 1987-10-06 WO PCT/JP1987/000749 patent/WO1988002264A1/ja active IP Right Grant
  • 1987-10-06 DE DE8787906471T patent/DE3785459T2/de not_active Expired - Lifetime
  • 1987-10-06 ES ES8702851A patent/ES2005028A6/es not_active Expired
  • 1987-10-06 EP EP87906471A patent/EP0365676B1/en not_active Expired - Lifetime
• 1988
  • 1988-06-04 KR KR1019880700634A patent/KR880701568A/ko not_active Application Discontinuation

Patent Citations (2)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events